Potent immune-dependent anticancer effects of the non-cardiotoxic anthracycline aclarubicin
Aclarubicin (also called aclacinomycin A) is an antineoplastic from the anthracycline class that is used in China and Japan but not in Europe nor in the USA. Aclarubicin induces much less DNA damage than the classical anthracyclines doxorubicin, daunorubicin, epirubicin, idarubicin, and the anthrace...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2025-12-01
|
| Reeks: | OncoImmunology |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/2162402X.2025.2515176 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|